| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |